Cargando…

Efficacy and safety of dabigatran versus warfarin from the RE-LY trial

BACKGROUND: Current data for atrial fibrillation (AF) and stroke are predominantly derived from North American and European patients. Although the burden of AF is high in Latin America (LA), little is known about current management of AF in the region. METHODS: We aimed to assess the consistency of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avezum, Alvaro, Oliveira, Gustavo Bernardes de Figueiredo, Diaz, Rafael, Hermosillo, Jesus Antonio Gonzalez, Oldgren, Jonas, Ripoll, Ernesto Ferreiros, Noack, Herbert, Piegas, Leopoldo Soares, Connolly, Stuart J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Arrhythmias and Sudden Death
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045746/ https://www.ncbi.nlm.nih.gov/pubmed/30018769 http://dx.doi.org/10.1136/openhrt-2018-000800

Ejemplares similares

Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
por: Friberg, Leif, et al.
Publicado: (2017)

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
por: Providência, Rui, et al.
Publicado: (2014)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K antagonist treatment to dabigatran
por: Choi, Eue-Keun, et al.
Publicado: (2020)

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
por: Allan, Victoria, et al.
Publicado: (2017)

Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study)
por: Vinereanu, Dragos, et al.
Publicado: (2020)

High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme
por: Sandhu, Roopinder K, et al.
Publicado: (2016)

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
por: Martin, Ruairidh I R, et al.
Publicado: (2014)

Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registry
por: Blom, M T, et al.
Publicado: (2014)

Sudden Unexpected Death in North Carolina (SUDDEN): methodology review and screening results
por: Nanavati, Parin P, et al.
Publicado: (2014)

A pilot study of angiotensin converting enzyme (ACE) genotype and return of spontaneous circulation following out-of-hospital cardiac arrest
por: Lindner, Thomas W, et al.
Publicado: (2014)

Feasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centre
por: McMillan, Merlin Ranald, et al.
Publicado: (2014)

Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender
por: Kwon, Deborah H, et al.
Publicado: (2014)

Heart rate is associated with progression of atrial fibrillation, independent of rhythm
por: Holmqvist, Fredrik, et al.
Publicado: (2015)

Routine issuance of clinical magnets to patients receiving implantable defibrillators: retention of information and appropriateness of use
por: Thomas, Dewi E, et al.
Publicado: (2015)

The 7-year teesside experience of primary prevention ICD indications following primary PCI (PPCI) and the potential impact of a change in NICE guidance
por: Phan, Thanh Trung, et al.
Publicado: (2015)

Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study
por: Sandgren, Emma, et al.
Publicado: (2015)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports
por: Chavez, Patricia, et al.
Publicado: (2015)

Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome
por: Raine, Daniel, et al.
Publicado: (2015)

Comparison of three current sets of electrocardiographic interpretation criteria for use in screening athletes
por: Riding, Nathan R, et al.
Publicado: (2015)

A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?
por: Ezzat, Vivienne A, et al.
Publicado: (2015)

Long-term risk of atrial fibrillation after the death of a partner
por: Graff, Simon, et al.
Publicado: (2016)

Opportunistic detection of atrial fibrillation using blood pressure monitors: a systematic review
por: Kane, Sarah A, et al.
Publicado: (2016)

Estimated incidence and risk factors of sudden unexpected death
por: Lewis, Mary Elizabeth, et al.
Publicado: (2016)

Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study
por: Fauchier, Laurent, et al.
Publicado: (2015)

Exercise-related sudden cardiac arrest in London: incidence, survival and bystander response
por: Edwards, Melanie J, et al.
Publicado: (2015)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
por: Camm, A John, et al.
Publicado: (2017)

Long-term outcomes after ablation of persistent atrial fibrillation: an observational study over 6 years
por: Wynn, Gareth J, et al.
Publicado: (2016)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Low incidence of left atrial delayed enhancement with MRI in patients with AF: a single-centre experience
por: Bois, John P, et al.
Publicado: (2017)

Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data
por: Murakami, Naoto, et al.
Publicado: (2017)

Clinical presentation of CIED infection following initial implant versus reoperation for generator change or lead addition
por: Harper, Mariko W, et al.
Publicado: (2018)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Association of QT interval with mortality by kidney function: results from the National Health and Nutrition Examination Survey (NHANES)
por: Malik, Rehan, et al.
Publicado: (2017)

Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score
por: Östman-Smith, Ingegerd, et al.
Publicado: (2017)

Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
por: Fradley, Michael G, et al.
Publicado: (2017)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Impact of periodontitis as representative of chronic inflammation on long-term clinical outcomes in patients with atrial fibrillation
por: Im, Sung Il, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_02t0e7qb7o2dqp1gh6iv2s2hsl